メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
Keio University ホーム
ヘルプ＆FAQ
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
Scopus著者プロファイル
吉本 憲史
内科学(腎臓・内分泌・代謝)
ウェブサイト
https://k-ris.keio.ac.jp/html/100003225_ja.html
h-index
129
被引用数
6
h 指数
Pureの文献数とScopusの被引用数に基づいて算出されます
2012
2024
年別の研究成果
概要
フィンガープリント
ネットワーク
研究成果
(28)
類似のプロファイル
(7)
フィンガープリント
Norifumi Yoshimotoが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Medicine and Dentistry
Acute Kidney Injury
28%
ANCA Associated Vasculitis
40%
Angiofollicular Lymph Node Hyperplasia
20%
Basement Membrane Antibody
20%
Calcineurin Inhibitor
20%
Chronic Kidney Disease
40%
Cognition
20%
Congenital Nephrotic Syndrome
20%
COVID-19
33%
Cytotoxic T-Cell
20%
Dialysis Catheter
20%
Disease
23%
DNA Damage
96%
DNA Methylation
100%
DNA Repair
30%
Donor Site
20%
Double Stranded DNA
41%
DRESS Syndrome
20%
Drug Hypersensitivity
22%
End Stage Renal Disease
19%
Eosinophilia
20%
Genetic Screening
18%
Glomerulus Filtration
21%
Heavy Meromyosin
20%
Hemodialysis
62%
Immunoglobulin A Nephropathy
42%
Infection
45%
Interstitial Nephritis
20%
Kidney Function
46%
Kidney Injury
20%
Kidney Transplantation
20%
Nephrin
16%
Nephrotic Syndrome
24%
Patient with Diabetes
20%
Patient with Hypertension
20%
Peritoneal Dialysis
60%
Plasminogen Activator Inhibitor-1
20%
Podocyte
66%
Potassium Chloride Cotransporter
20%
Proteinuria
59%
Pulmonary Hemorrhage
20%
Receptor Potential
20%
Renal Biopsy
20%
Retrospective Cohort Study
20%
Selectivity Index
20%
Severe Acute Respiratory Syndrome Coronavirus 2
20%
Symptom
34%
Tocilizumab
20%
Urinary System
32%
Vancomycin
20%
Keyphrases
2008 Wenchuan Earthquake
20%
Angiotensin
20%
Anti-GBM Antibodies
20%
CD8+ T Cells
20%
Cellular Crosstalk
20%
Chronic Kidney Disease Patients
20%
Clinical Significance
20%
Combination Therapy
20%
Connective Tissue Growth Factor
20%
DNA Damage
22%
DNA Methylation (DNAm)
40%
DNA Methylation Clock
20%
DNA Repair Factors
20%
Drug Hypersensitivity
20%
Drug Reaction
20%
Earthquake-induced
20%
EGFR Decline
25%
Eosinophilia
20%
Exit Site Care
20%
Fechtner Syndrome
20%
Glomerular Filtration
20%
Hemodialysis
22%
Hypertensive Patients
20%
Idiopathic multicentric Castleman Disease (iMCD)
20%
Inhibitor Combination
20%
Ischemic Kidney Injury
20%
KAT5
40%
Kidney Injury
20%
MRNA Vaccine
20%
Natural Disasters
20%
Nephrotic Syndrome
43%
Peritoneal Dialysis
20%
Pfizer-BioNTech
20%
Podocyte
40%
Proteinuria
43%
Regret
20%
Renal Fibrosis
20%
Renin-angiotensin System
20%
Retrospective Cohort Study
20%
Secondary Effects
20%
Surgical Adhesive
20%
Systemic Symptoms
20%
Thiazide Diuretics
20%
Tocilizumab
20%
Urea-to-creatinine Ratio
20%
Urinary Shedding
20%
Urinary Sodium Excretion
20%
Urine-derived Cells
20%
Vaccination
20%
Vancomycin
20%
Pharmacology, Toxicology and Pharmaceutical Science
Albuminuria
5%
Alzheimer's Disease
20%
ANCA Associated Vasculitis
20%
Angiotensin
20%
Antihypertensive Agent
5%
Cardiovascular Disease
20%
Chronic Kidney Failure
38%
Cognitive Defect
8%
Cohort Study
20%
Combination Therapy
20%
Connective Tissue Growth Factor
20%
Coronavirinae
23%
Deterioration
20%
Disease
25%
Diseases
6%
DNA Methyltransferase
5%
Double Stranded DNA
20%
DRESS Syndrome
20%
Eosinophilia
20%
Focal Glomerulosclerosis
6%
Hemodialysis
40%
Immunoglobulin G Antibody
6%
Infection
20%
Kidney Disease
20%
Kidney Fibrosis
20%
Lipopolysaccharide-Induced Sepsis
6%
Lung Hemorrhage
20%
Malignant Neoplasm
20%
Membranous Glomerulonephritis
9%
Mouse
13%
Mouse Model
20%
Nephrin
10%
Nephrotic Syndrome
20%
Peptide Vaccine
5%
Plasminogen Activator Inhibitor 1
20%
Proteinuria
20%
Remission
20%
Retrospective Study
5%
Rituximab
6%
SARS Coronavirus
20%
Symptom
27%
Thiazide Diuretic Agent
20%
Thrombosis
6%
Triacylglycerol
5%
Uric Acid
5%
Vaccination Policy
43%
Vaccine Attenuated
5%
Vancomycin
20%
Vasculitis
8%
